Recent News
Jul 28, 2021
MD Anderson and Blueprint Medicines Announce Strategic Collaboration to Accelerate BLU-222 Development
Events and presentations
Aug 10, 2021
2021 Wedbush Pacgrow Healthcare Virtual Conference
Jul 29, 2021
Q2 2021 Blueprint Medicines Corp Conference Call
Our commitment to patients
At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve the lives of people with genomically defined diseases.
read onClinical programs
Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc.
Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc.
Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc.
Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc.
Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc.
Meet the Blue Crew
Meet the Blue Crew
Andrew Kim, Head of International Strategy and Business Operations
As Blueprint Medicines’ Head of International Strategy and Business Operations, my role is to strategically plan and lead outreach to clinical investigators, healthcare providers and laboratories outside the United States to support the company’s portfolio of clinical-stage programs.
Read onWe aspire to pioneer multiple new scientific advances in disease biology and the design of precision therapies. To learn more about our scientific leadership and perspectives, visit The Lens.
read on
“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat cancer.”Jeff Albers, Chief Executive Officer
“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat cancer.”Jeff Albers, Chief Executive Officer
Dare to be different
We believe diversity is the key to unlocking our full potential. We push boundaries and take well-calculated risks, committing courageously and wholeheartedly to what we believe in.
read on